Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D J Baker

Showing results (81-90 of 97) with videos related to

Pageof 10
Sort By:
Epidemiology and Infection|December 1, 1990
Acute upper respiratory tract viral illness and influenza immunization in homes for the elderlyK G Nicholson, D J Baker, A Farquhar, et al.
British Journal of Pharmacology|April 29, 2014
Characterization of the heterozygous glucokinase knockout mouse as a translational disease model for glucose control in type 2 diabetesD J Baker, A M Atkinson, G P Wilkinson, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 10, 2004
The effect of the beta2-adrenoceptor agonist prodrug BRL-47672 on cardiovascular function, skeletal muscle myosin heavy chain, and MyoD expression in the ratS W Jones, D J Baker, S M Gardiner, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 18, 1997
Nucleoprotein-based nanoscale assemblyS S Smith, L Niu, D J Baker, et al.
Biochemical and Biophysical Research Communications|May 29, 1987
Size of the directing moiety at carbon 5 of cytosine and the activity of human DNA(cytosine-5) methyltransferaseT A Hardy, D J Baker, E M Newman, et al.
Nucleic Acids Research|May 25, 1988
RglB facilitated cloning of highly methylated eukaryotic DNA: the human L1 transposon, plant DNA, and DNA methylated in vitro with human DNA methyltransferaseD M Woodcock, P J Crowther, W P Diver, et al.
British Journal of Pharmacology|April 29, 2014
Chronic glucokinase activator treatment at clinically translatable exposures gives durable glucose lowering in two animal models of type 2 diabetesD J Baker, G P Wilkinson, A M Atkinson, et al.
Age and Ageing|May 1, 1992
Immunogenicity of inactivated influenza vaccine in residential homes for elderly peopleK G Nicholson, D J Baker, P Chakraverty, et al.
FEBS Letters|April 6, 1981
The binding of trimethoprim to bacterial dihydrofolate reductaseD J Baker, C R Beddell, J N Champness, et al.
Clinical Chemistry|December 4, 1998
Evaluation of an immunoseparation method for quantitative measurement of remnant-like particle-cholesterol in serum and plasmaE T Leary, T Wang, D J Baker, et al.
Pageof 10

Showing results (81-90 of 97) with videos related to

Sort By:
Pageof 10
Epidemiology and Infection|December 1, 1990
Acute upper respiratory tract viral illness and influenza immunization in homes for the elderlyK G Nicholson, D J Baker, A Farquhar, et al.
British Journal of Pharmacology|April 29, 2014
Characterization of the heterozygous glucokinase knockout mouse as a translational disease model for glucose control in type 2 diabetesD J Baker, A M Atkinson, G P Wilkinson, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 10, 2004
The effect of the beta2-adrenoceptor agonist prodrug BRL-47672 on cardiovascular function, skeletal muscle myosin heavy chain, and MyoD expression in the ratS W Jones, D J Baker, S M Gardiner, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 18, 1997
Nucleoprotein-based nanoscale assemblyS S Smith, L Niu, D J Baker, et al.
Biochemical and Biophysical Research Communications|May 29, 1987
Size of the directing moiety at carbon 5 of cytosine and the activity of human DNA(cytosine-5) methyltransferaseT A Hardy, D J Baker, E M Newman, et al.
Nucleic Acids Research|May 25, 1988
RglB facilitated cloning of highly methylated eukaryotic DNA: the human L1 transposon, plant DNA, and DNA methylated in vitro with human DNA methyltransferaseD M Woodcock, P J Crowther, W P Diver, et al.
British Journal of Pharmacology|April 29, 2014
Chronic glucokinase activator treatment at clinically translatable exposures gives durable glucose lowering in two animal models of type 2 diabetesD J Baker, G P Wilkinson, A M Atkinson, et al.
Age and Ageing|May 1, 1992
Immunogenicity of inactivated influenza vaccine in residential homes for elderly peopleK G Nicholson, D J Baker, P Chakraverty, et al.
FEBS Letters|April 6, 1981
The binding of trimethoprim to bacterial dihydrofolate reductaseD J Baker, C R Beddell, J N Champness, et al.
Clinical Chemistry|December 4, 1998
Evaluation of an immunoseparation method for quantitative measurement of remnant-like particle-cholesterol in serum and plasmaE T Leary, T Wang, D J Baker, et al.
Pageof 10